Biomolecular Screening - The Online Scientific Community

This website and its affiliated micro-sites are owned and published by Technology Networks Ltd.

To ensure that you get the most from our website, we are committed to optimizing the site to match your needs, so it is easier for you to find the content and services most relevant to your work and keeping access to most of our content and services free of charge. We endeavour to exceed the strict privacy practices required by the United States CAN-SPAM Act of 2003, the United Kingdom Data Protection Act and the 2002 European Directive on Privacy and Electronic Communications. If, however, you would like to make a query regarding our privacy policy please contact us.

Information we collect from you

Site visitors are required to complete a registration process. By registering, visitors provide us with information about who they are, the work they do, and their interests. Once registration is complete no further information of this sort is required for free access to this site. Further personal information from visitors may be required to participate in the online Forums. We may also collect information regarding your use of the websites by monitoring the use of cookies.

How we use Personal Information The information that we gather is used in a variety of ways. The first is to build up a demographic profile of our membership, allowing us to better match our content and services to the interests of our members. Obviously, the more accurate the information provided by each member, the better we can do this. For this reason, visitors are encouraged to regularly update their profiles to provide us with the most accurate information possible.

We may disclose your information to other companies in order to ensure the smooth provision of services that you have booked with us. If you have made a booking with us your data will be principally used to provide you with your purchase as well as your registration or other services and facilities.

Your details may be shared within the Technology Networks and Select Biosciences group. Please click here for a list of websites and company details. These companies may use your details to send you information about products, promotions and special offers that we think may interest you.

The information is also used in our dealings with the third parties with whom we work. The co-operation of the companies that supply us with content and services and the revenue derived from advertising and sponsorship allow us to keep access to our sites free of charge. In order to provide incentives for these third parties to continue working with us, Technology Networks Ltd. does share some information about our visitors, as detailed below.

We may monitor the activity of visitors accessing the site and share data about this activity with publishers and advertisers. However, personal data about an individual member is only provided to third parties if the visitor has given us prior consent to do so by ticking the relevant box in our registration form.

Personal data about individual members is never shared with a third party we do not consider to be reputable and is only made available to companies who are actively supporting free access to the content and services provided by our sites. Visitors should note however that, if they enter another site from a link within a Technology Networks Ltd. site, they are no longer covered by this privacy policy.

How you can access and update your data

We have designed our websites so that it is easy for you to access and update the personal information that you saved with us. After you log in you will be provided with a link that will allow you to access and update your details. Individual eNewsletters can be immediately unsubscribed by clicking an unsubscribe link within them. If you require further assistance on updating your details please contact us.

Changes to this policy If at any point we decide to use your personally identifiable information in any way other that described in this privacy policy we will notify you by way of email or by 30 days notice on the website. Please note that we retain the right to change this policy at any time. Technology Networks Ltd. continues to invest in the best quality security available and we do our utmost to protect visitor privacy. If you have any queries regarding this privacy policy or the way we collect and gather information about our members, please e-mail your comments and questions to support@technologynetworks.com

Selecting IVF Embryos for Normal Numbers of Chromosomes can Significantly Increase Pregnancy Rates
First randomized prospective study shows ongoing pregnancy rate after 20 weeks per cycle started of 69.1% in the 24sure treatment group vs 41.7% in the control group.

Promise of Structure-Based Drug Design for GPCRs
Heptares Therapeutics announces the recent publication of a major review of the state of the art for GPCR drug discovery and new insights that, for the first time, can be obtained from structural biology.

New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.

Guidelines for Prostate Screening Widely Ignored, Study Finds
2008 recommendations from federal task force had no impact.

Researchers Turn Big Data Problems into Advanced Biology and Drug Discoveries
University of Illinois at Chicago and The Genome Analysis Centre in Norwich, UK leverage SGI(R) UV(TM) to accelerate drug discovery and complex problem analysis.

New Research on Zebrafish Brings a Cure for Hearing Loss Closer
Zebrafish to discover drugs that may lead to the restoration of hearing.

Completion of Alzheimer’s Plasma Biomarker Study
The preliminary results demonstrate significant diagnostic and prognostic utilities.

ERSPC Latest Findings Confirm Increased Mortality Benefit from Prostate Cancer Testing
Extended follow up needed to establish full impact of screening.

Broad Institute, Dana-Farber and Novartis Collaborate to Develop Cancer Cell Line Encyclopedia
Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.

Specificity Quantification of Biomolecular Recognition and its Implication for Drug Discovery
Highly efficient and specific biomolecular recognition requires both affinity and specificity. Here scientists developed a novel method SPA (SPecificity and Affinity) based on funneled energy landscape theory, with increased specificity on previous models.